View in EDS PDF Full Text

Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.

Saved in:
Bibliographic Details
Title: Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
Authors: Stasch JP; Institute of Cardiovascular Research, Bayer HealthCare, Wuppertal, Germany., Schmidt PM, Nedvetsky PI, Nedvetskaya TY, H S AK, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Müller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, Müller-Esterl W, Schmidt HH
Source: The Journal of clinical investigation [J Clin Invest] 2006 Sep; Vol. 116 (9), pp. 2552-61.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Print ISSN: 0021-9738 (Print) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 16955146
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stasch+JP%22">Stasch JP</searchLink>; Institute of Cardiovascular Research, Bayer HealthCare, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidt+PM%22">Schmidt PM</searchLink><br /><searchLink fieldCode="AU" term="%22Nedvetsky+PI%22">Nedvetsky PI</searchLink><br /><searchLink fieldCode="AU" term="%22Nedvetskaya+TY%22">Nedvetskaya TY</searchLink><br /><searchLink fieldCode="AU" term="%22H+S+AK%22">H S AK</searchLink><br /><searchLink fieldCode="AU" term="%22Meurer+S%22">Meurer S</searchLink><br /><searchLink fieldCode="AU" term="%22Deile+M%22">Deile M</searchLink><br /><searchLink fieldCode="AU" term="%22Taye+A%22">Taye A</searchLink><br /><searchLink fieldCode="AU" term="%22Knorr+A%22">Knorr A</searchLink><br /><searchLink fieldCode="AU" term="%22Lapp+H%22">Lapp H</searchLink><br /><searchLink fieldCode="AU" term="%22Müller+H%22">Müller H</searchLink><br /><searchLink fieldCode="AU" term="%22Turgay+Y%22">Turgay Y</searchLink><br /><searchLink fieldCode="AU" term="%22Rothkegel+C%22">Rothkegel C</searchLink><br /><searchLink fieldCode="AU" term="%22Tersteegen+A%22">Tersteegen A</searchLink><br /><searchLink fieldCode="AU" term="%22Kemp-Harper+B%22">Kemp-Harper B</searchLink><br /><searchLink fieldCode="AU" term="%22Müller-Esterl+W%22">Müller-Esterl W</searchLink><br /><searchLink fieldCode="AU" term="%22Schmidt+HH%22">Schmidt HH</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2006 Sep; Vol. 116 (9), pp. 2552-61.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0021-9738 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16955146
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI28371
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2552
    Titles:
      – TitleFull: Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stasch JP
      – PersonEntity:
          Name:
            NameFull: Schmidt PM
      – PersonEntity:
          Name:
            NameFull: Nedvetsky PI
      – PersonEntity:
          Name:
            NameFull: Nedvetskaya TY
      – PersonEntity:
          Name:
            NameFull: H S AK
      – PersonEntity:
          Name:
            NameFull: Meurer S
      – PersonEntity:
          Name:
            NameFull: Deile M
      – PersonEntity:
          Name:
            NameFull: Taye A
      – PersonEntity:
          Name:
            NameFull: Knorr A
      – PersonEntity:
          Name:
            NameFull: Lapp H
      – PersonEntity:
          Name:
            NameFull: Müller H
      – PersonEntity:
          Name:
            NameFull: Turgay Y
      – PersonEntity:
          Name:
            NameFull: Rothkegel C
      – PersonEntity:
          Name:
            NameFull: Tersteegen A
      – PersonEntity:
          Name:
            NameFull: Kemp-Harper B
      – PersonEntity:
          Name:
            NameFull: Müller-Esterl W
      – PersonEntity:
          Name:
            NameFull: Schmidt HH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2006 Sep
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 0021-9738
          Numbering:
            – Type: volume
              Value: 116
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1